Infectious Disease — Pharmacokinetics Simulators

12 interactive PK simulators available for infectious disease drugs.

About Infectious Disease Pharmacokinetics

Infectious disease pharmacokinetics is essential for optimizing antimicrobial therapy. PK/PD indices such as AUC/MIC, Cmax/MIC, and T>MIC guide dosing to maximize bacterial kill while minimizing resistance development. Therapeutic drug monitoring is standard practice for aminoglycosides, vancomycin, and antifungals.

Small Molecule

Compare →

Biktarvy (Bictegravir/Emtricitabine/TAF)

Oral• 1-CMT PopPK

HIV-1 infection

Ganciclovir

IV/Oral• PK/PD

CMV Infection

Oxacillin Neonatal

IV• PopPK

MSSA Infections (Neonates)

Paxlovid (Nirmatrelvir/Ritonavir)

Oral• 1-CMT PopPK

COVID-19 treatment

Voriconazole IV

IV• PopPK

Invasive Fungal Infections

Aminoglycoside

Gentamicin TDM

IV• popPK

Bacterial infections

Antibiotics

Antibiotic PD Interaction

IV/Oral• Pharmacodynamic Interaction

Bacterial infections

Benzimidazole Anthelminthic

Oxfendazole Population

Oral• Population PK (1-CMT drug-metabolite, first-pass)

Onchocerciasis (river blindness)

Fluoroquinolone

Ciprofloxacin

Oral/IV• popPK

Bacterial infections

Glycopeptide

Vancomycin TDM

IV• popPK

Bacterial infections

Rifamycin

Rifampicin

Oral• popPK

Tuberculosis

Triazole Antifungal

Voriconazole

IV• One-compartment PopPK

Invasive aspergillosis, candidemia

Disclaimer: These simulators are for educational and research purposes only. Pharmacokinetic models are based on published literature and may not reflect individual patient variability. Not intended for clinical decision-making. Always consult prescribing information and clinical guidelines.

← All AreasAll SimulatorsCompare Drugs →